Nereus (tradipitant)
New molecular entity
- Region
- 🇺🇸 US
- Active substance
- tradipitant
- Company
- Vanda Pharms Inc
- Status
- Approved
- FDA approval
- Tue 30 Dec 2025
- Designations
- New molecular entity
- Application
- NDA220152
- Official record
- www.accessdata.fda.gov
Regulatory milestones
Tue 30 Dec 2025🇺🇸 FDA approval
FDA approves Nereus (tradipitant), a new medicine
Vanda Pharms Inc; NDA220152; New molecular entity; capsule · source
Follow Nereus
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.